Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A medicament for treating cerebrovascular disease

A technology for cerebrovascular diseases and drugs, which is applied in the field of traditional Chinese medicine, can solve the problems that scutellarin is not easy to pass through the blood-brain barrier, inconvenient injection and administration, and limited curative effect, so as to improve the prevention and treatment effect and reduce the risk of systemic Sexual side effects, avoiding the effect of high risk of surgery

Inactive Publication Date: 2006-12-13
ZHEJIANG CHINESE MEDICAL UNIVERSITY
View PDF0 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Due to the conventional route (gastrointestinal tract, intravenous) administration, scutellarin is not easy to penetrate the blood-brain barrier, the curative effect is limited, and most cerebrovascular diseases require long-term medication, injection administration is inconvenient, and the safety of traditional Chinese medicine injection is a problem. big problem

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] Embodiment 1 preparation solution (can be used as nasal drops, spray)

[0036] Breviscapine 1.0g

[0037] EDTA-2Na 0.1g

[0038] Sodium metabisulfite 0.15g

[0039] Benzalkonium Chloride 0.01g

[0040] pH7.5 Phosphate Buffer Add to 100ml

[0041] The above-mentioned components are prepared into nasal drops or nasal sprays of breviscapine according to conventional methods.

Embodiment 2

[0042] Example 2 Preparation of gel (can be used as nasal drops, spray)

[0043] Breviscapine 1.0g

[0044] Carbopol 934PNF 0.5g

[0045] Sorbitol 4.0g

[0046] EDTA-2Na 0.1g

[0047] Sodium metabisulfite 0.15g

[0048] Benzalkonium Chloride 0.01g

[0049] 1moI / L NaOH to adjust the pH to 6-7

[0050] Distilled water to 100ml

[0051] Add the above-mentioned breviscapine, Carbopol 934PNF, sorbitol, EDTA-2Na, sodium metabisulfite, and benzalkonium chloride into 50ml of distilled water, stir magnetically for 24 hours, adjust the pH to 6-7 with 1mol / L NaOH to form a gel, add distilled water to 100ml to obtain light yellow gel.

Embodiment 3

[0052] Example 3 Preparation of powder

[0053] Breviscapine 1.0g

[0054] Lactose 30.0g

[0055] pH6.5-7.5 Phosphate Buffer 100ml

[0056] Add the above-mentioned scutellarin and lactose into 100ml of phosphate buffer, stir until completely dissolved, freeze-dry at -35~C overnight, then freeze-dry at -10~C and 0~C for 24 hours, pass through a 180-mesh sieve, For nasal inhalation or spray.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicament for treating cardiovascular and cerebrovascular diseases, which is prepared from original-shaped medicament of Breviscapine or its pharmaceutically acceptable salts as the active constituents. The medicament can be made into nasal preparation, wherein each 1g of the medicament contain 1-200mg of the active constituents

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine pharmacy, in particular to a medicine for treating cerebral infarction, migraine, vascular dementia and other cerebrovascular diseases. Background technique [0002] Cerebrovascular diseases are a group of diseases that occur in the blood vessels of the brain and cause brain tissue damage due to intracranial blood circulation disorders. They are divided into ischemic cerebrovascular diseases and hemorrhagic cerebrovascular diseases. With the advent of my country's aging society, changes in social life behavior and environmental factors, cerebrovascular disease is not only a major disease that endangers human health, but will also be the "number one killer" of human death and disability in the next 20 years. [0003] However, due to the special anatomical structure and physiological importance of the brain, the application of surgery in the treatment of cereb...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/28A61K31/7048A61K9/00A61P9/10A61P25/06A61P25/28
Inventor 石森林徐莲英储利胜李昌煜葛卫红吴瑾瑾沈炜张晓东毛展凯
Owner ZHEJIANG CHINESE MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com